Renaissance Technologies LLC Sells 32,900 Shares of ZimVie Inc. (NASDAQ:ZIMV)

Renaissance Technologies LLC cut its holdings in shares of ZimVie Inc. (NASDAQ:ZIMV) by 8.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 356,300 shares of the company’s stock after selling 32,900 shares during the period. Renaissance Technologies LLC owned 1.29% of ZimVie worth $4,970,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of ZIMV. Barclays PLC lifted its holdings in ZimVie by 338.4% in the third quarter. Barclays PLC now owns 43,437 shares of the company’s stock valued at $690,000 after buying an additional 33,529 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of ZimVie by 66.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company’s stock valued at $2,911,000 after purchasing an additional 73,395 shares during the period. Geode Capital Management LLC boosted its position in shares of ZimVie by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 646,564 shares of the company’s stock worth $10,263,000 after purchasing an additional 15,053 shares during the last quarter. Principal Financial Group Inc. acquired a new stake in shares of ZimVie during the third quarter worth $275,000. Finally, Bank of New York Mellon Corp increased its holdings in ZimVie by 0.9% in the fourth quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company’s stock valued at $1,404,000 after purchasing an additional 943 shares during the last quarter. Institutional investors own 95.63% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on ZIMV shares. B. Riley began coverage on ZimVie in a report on Thursday, April 10th. They set a “buy” rating and a $16.00 target price on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of ZimVie in a research note on Wednesday, April 9th.

ZimVie Stock Up 1.5 %

Shares of ZimVie stock opened at $9.39 on Monday. The company has a market capitalization of $261.48 million, a P/E ratio of -0.72 and a beta of 2.14. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. The business has a 50-day moving average of $11.55 and a two-hundred day moving average of $13.26. ZimVie Inc. has a 1 year low of $8.56 and a 1 year high of $22.40.

ZimVie (NASDAQ:ZIMV) last posted its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.02. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. The business had revenue of $111.52 million during the quarter, compared to analysts’ expectations of $113.67 million. As a group, equities analysts predict that ZimVie Inc. will post 0.6 EPS for the current year.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.